Epidemiological, Clinical, Therapeutic and Evolutionary Profile of HIV-infected Patients Monitored at the Center of Excellence of the University of Lubumbashi
Journal of AIDS and HIV Treatment · 2025
DOI: 10.33696/aids.7.062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of AIDS and HIV Treatment, 2025. Verfasst von Philomène Lungu Anzwal und 20 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
HIV infection is characterized by the progressive destruction of CD4+ T lymphocytes, responsible for an immune deficiency, thus promoting the development of serious opportunistic infections and tumors.
Aim
The objective of this study was to describe the epidemiological, clinical, therapeutic, and disease progression of HIV-infected patients registered and monitored at the Center of Excellence at the University of Lubumbashi.
Methods
Retrospective descriptive study, carried out from 2006 to 2024 using patient records registered at the Center of Excellence. Data were collected using a previously established survey form. Variables collected: socio-demographic variables, opportunistic infections, stages of infection, antiretrovirals, treatment-related complications, mode of HIV transmission, and treatment progress. Data analysis was performed using SPSS 30.0 software. We calculated position and dispersion parameters.
Results
We collected 8,912 cases of HIV infection (24.95%) from a sample of 35,716 patients screened, including 5,271 women (59.1%) and 3,641 men (40.9%). The mean age was 35 ± 0.3 years. Opportunistic infections were dominated by pulmonary (31%) and extrapulmonary (8.8%) tuberculosis, digestive candidiasis (32.5%), cerebral toxoplasmosis (14.9%), isosporiasis (7.4%), herpes simplex (3.1%), cryptococcal meningitis (3.9%), vaginal candidiasis (3.7%), prurigo (3.3%), shingles (2.3%), Kaposi's sarcoma (2.2%), and diarrhea without isolated germs (2.1%). 99.6% of patients were receiving first-line treatment: tenofovir, lamivudine, and dolutegravir. The progression was marked by a death rate of 19.11%, significantly related to infections (p
Zitieren
APA
Anzwal, P. L., Mukendi, D. M., Panshi, O. P. W., Kambote, A. K., Mutombo, N. M., Kanyama, A. L., Ebondo, J. N., Madika, S. M., Tshinyengo, F. K., Ilunga, J., Dina, M., Babile, G. M., Lwamba, G. K., Mankoy, E. N., Ampeng, O. L., Yatambo, E. K., Lombe, D. E., Monga, D. B., Kwete, L. S., …, & Kitenge, T. K. (2025). Epidemiological, Clinical, Therapeutic and Evolutionary Profile of HIV-infected Patients Monitored at the Center of Excellence of the University of Lubumbashi. Journal of AIDS and HIV Treatment. https://doi.org/10.33696/aids.7.062
Vancouver
Anzwal PL, Mukendi DM, Panshi OPW, Kambote AK, Mutombo NM, Kanyama AL, et al. Epidemiological, Clinical, Therapeutic and Evolutionary Profile of HIV-infected Patients Monitored at the Center of Excellence of the University of Lubumbashi. Journal of AIDS and HIV Treatment. 2025. doi:10.33696/aids.7.062
BibTeX
@article{Anzwal2025,
author = {Anzwal, Philomène Lungu and Mukendi, Dodo Manda and Panshi, Odon Panshi Wa and Kambote, Athy Kalumba and Mutombo, Nathalie Mbuyamba and Kanyama, Astrid Lokotshe and Ebondo, Jirène Ndibu and Madika, Salvatrice Masonga and Tshinyengo, Franck Kasans and Ilunga, Julie and Dina, Mbelu and Babile, Gloria Malitele and Lwamba, Guy Kandja and Mankoy, Eric Ngindu and Ampeng, Odile Latshupanda and Yatambo, Elie Kabika and Lombe, David Elo and Monga, Djo Banza and Kwete, Laurent Shamashanga and Lukamba, Jérôme Nyembo and Kitenge, Tony Kayembe},
title = {Epidemiological, Clinical, Therapeutic and Evolutionary Profile of HIV-infected Patients Monitored at the Center of Excellence of the University of Lubumbashi},
journal = {Journal of AIDS and HIV Treatment},
year = {2025},
doi = {10.33696/aids.7.062}
}
EUVIMED